semaglutide lawsuit 2025 Lawsuits claiming Ozempic, other GLP-1s led to blindness become second mass litigation over the drugs Ozempic Lawsuit 2025: Legal Support

It can impair judgment and decision-making, leading to risky behaviors such as unprotected sex, violence, or accidents

Verzehrempfehlung: Tglich 2 Kapseln unzerkaut mit ausreichend Flssigkeit einnehmen

Participants were randomly assigned to receive one of several doses of subcutaneous retatrutide 1 mg, 4 mg, 8 mg, or 12 mg or placebo, administered once weekly

Compounded drugs should only be used to meet a patients needs if the patients medical needs cannot be met by an available FDA-approved drug, the FDA said

44,45 Using the FDA Sentinel System, Maro et al found that the incidence of NAION was not increased within 6 months of semaglutide initiation